Emukule Gideon O, Spreeuwenberg Peter, Chaves Sandra S, Mott Joshua A, Tempia Stefano, Bigogo Godfrey, Nyawanda Bryan, Nyaguara Amek, Widdowson Marc-Alain, van der Velden Koos, Paget John W
Centers for Disease Control and Prevention - Kenya Country Office, Nairobi, Kenya.
Radboud University Medical Center, Department of Primary and Community care, Nijmegen, The Netherlands.
PLoS One. 2017 Jul 7;12(7):e0180890. doi: 10.1371/journal.pone.0180890. eCollection 2017.
Influenza and respiratory syncytial virus (RSV) associated mortality has not been well-established in tropical Africa.
We used the negative binomial regression method and the rate-difference method (i.e. deaths during low and high influenza/RSV activity months), to estimate excess mortality attributable to influenza and RSV using verbal autopsy data collected through a health and demographic surveillance system in Western Kenya, 2007-2013. Excess mortality rates were calculated for a) all-cause mortality, b) respiratory deaths (including pneumonia), c) HIV-related deaths, and d) pulmonary tuberculosis (TB) related deaths.
Using the negative binomial regression method, the mean annual all-cause excess mortality rate associated with influenza and RSV was 14.1 (95% confidence interval [CI] 0.0-93.3) and 17.1 (95% CI 0.0-111.5) per 100,000 person-years (PY) respectively; and 10.5 (95% CI 0.0-28.5) and 7.3 (95% CI 0.0-27.3) per 100,000 PY for respiratory deaths, respectively. Highest mortality rates associated with influenza were among ≥50 years, particularly among persons with TB (41.6[95% CI 0.0-122.7]); and with RSV were among <5 years. Using the rate-difference method, the excess mortality rate for influenza and RSV was 44.8 (95% CI 36.8-54.4) and 19.7 (95% CI 14.7-26.5) per 100,000 PY, respectively, for all-cause deaths; and 9.6 (95% CI 6.3-14.7) and 6.6 (95% CI 3.9-11.0) per 100,000 PY, respectively, for respiratory deaths.
Our study shows a substantial excess mortality associated with influenza and RSV in Western Kenya, especially among children <5 years and older persons with TB, supporting recommendations for influenza vaccination and efforts to develop RSV vaccines.
在热带非洲,流感和呼吸道合胞病毒(RSV)相关的死亡率尚未得到充分证实。
我们使用负二项回归法和率差法(即流感/RSV活动低峰期和高峰期的死亡人数),利用2007年至2013年在肯尼亚西部通过健康和人口监测系统收集的死因推断数据,估算流感和RSV导致的额外死亡率。计算了以下几类的额外死亡率:a)全因死亡率;b)呼吸道死亡(包括肺炎);c)与艾滋病毒相关的死亡;d)与肺结核(TB)相关的死亡。
使用负二项回归法,与流感和RSV相关的年平均全因额外死亡率分别为每10万人年14.1(95%置信区间[CI] 0.0 - 93.3)和17.1(95% CI 0.0 - 111.5);呼吸道死亡的额外死亡率分别为每10万人年10.5(95% CI 0.0 - 28.5)和7.3(95% CI 0.0 - 27.3)。与流感相关的最高死亡率出现在≥50岁人群中,尤其是患有肺结核的人群(41.6[95% CI 0.0 - 122.7]);与RSV相关的最高死亡率出现在<5岁人群中。使用率差法,流感和RSV的全因死亡额外死亡率分别为每10万人年44.8(95% CI 36.8 - 54.4)和19.7(95% CI 14.7 - 26.5);呼吸道死亡的额外死亡率分别为每10万人年9.6(95% CI 6.3 - 14.7)和6.6(95% CI 3.9 - 11.0)。
我们的研究表明,在肯尼亚西部,流感和RSV与相当高的额外死亡率相关,尤其是在<5岁儿童和患有肺结核的老年人中,这支持了流感疫苗接种建议以及研发RSV疫苗的努力。